NO20055230L - HIV-integraseinhibitorer - Google Patents

HIV-integraseinhibitorer

Info

Publication number
NO20055230L
NO20055230L NO20055230A NO20055230A NO20055230L NO 20055230 L NO20055230 L NO 20055230L NO 20055230 A NO20055230 A NO 20055230A NO 20055230 A NO20055230 A NO 20055230A NO 20055230 L NO20055230 L NO 20055230L
Authority
NO
Norway
Prior art keywords
optionally
substituted
multisubstituted
het2
nr8r9
Prior art date
Application number
NO20055230A
Other languages
English (en)
Inventor
Wim Gaston Verschueren
Dominique Louis Nest Surleraux
Frederik Frans Desire Daeyaert
Inge Dierynck
Original Assignee
Tibtec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibtec Pharmaceuticals Ltd filed Critical Tibtec Pharmaceuticals Ltd
Publication of NO20055230L publication Critical patent/NO20055230L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A, sammen med de to karbonatomer av fenylringen som den er bundet til, danner monocyklisk aryl eller monocyklisk Het2; R1 er hydrogen, halo, nitro, cyano, sultam, sultim, C3.7-cykloalkyl, C(=O)-R5, S(=O)y-R6, OR7, NR8R9, C(=NR8)-R5, valgfritt flersubstituert C^-alkyl, valgfritt flersubsti-tuert C2.6-alkenyl eller valgfritt flersubstituert C2.6-alkynyl; R2 er hydrogen, C3.7-cykloalkyl, aryl, Het1, Het2, C(=O)-R5, S(=O)y-R6, OR7, NR8R9, C (=NR8) -R5 eller valgfritt flersubstituert C^g-alkyl, valgfritt flersubstituert C2.6-alkenyl eller valgfritt flersubstituert C2.6-alkynyl. Anvendelse derav som HIV-integraseinhibitorer, fremgangs-mater for deres fremstilling samt farmasoytiske sammenset-ninger og diagnostiske sett som inneholder dem. Dessuten kombinasjoner derav med andre anti-retrovirale midler og deres anvendelse i assayer som referanseforbindelser eller som reagensmidler.
NO20055230A 2003-04-28 2005-11-07 HIV-integraseinhibitorer NO20055230L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46598703P 2003-04-28 2003-04-28
EP03101164 2003-04-28
PCT/EP2004/050621 WO2004096807A2 (en) 2003-04-28 2004-04-27 Hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
NO20055230L true NO20055230L (no) 2005-11-07

Family

ID=33420586

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055230A NO20055230L (no) 2003-04-28 2005-11-07 HIV-integraseinhibitorer

Country Status (13)

Country Link
US (1) US20060211724A1 (no)
EP (1) EP1625130A2 (no)
KR (1) KR20060006047A (no)
CN (1) CN1812992A (no)
AP (1) AP2005003451A0 (no)
AR (1) AR044518A1 (no)
AU (1) AU2004234087A1 (no)
BR (1) BRPI0409873A (no)
CA (1) CA2522990A1 (no)
MX (1) MXPA05011726A (no)
NO (1) NO20055230L (no)
TW (1) TW200507848A (no)
WO (1) WO2004096807A2 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200716632A (en) * 2005-05-16 2007-05-01 Gilead Sciences Inc Integrase inhibitor compounds
EP1885722B1 (en) 2005-05-19 2011-11-16 Merck Canada Inc. Quinoline derivatives as ep4 antagonists
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
WO2007014352A2 (en) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Antiviral phosphonate conjugates for inhibition of hiv
WO2007076005A2 (en) * 2005-12-21 2007-07-05 Gilead Sciences, Inc. Processes and intermediates useful for preparing integrase inhibitor compounds
CA2651579A1 (en) * 2006-05-16 2007-11-29 Gilead Sciences, Inc. Integrase inhibitors
EP1916249A1 (en) * 2006-10-10 2008-04-30 LEK Pharmaceuticals D.D. 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
DK2124562T3 (en) 2007-03-09 2016-08-01 Second Genome Inc BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof
WO2009067541A2 (en) * 2007-11-20 2009-05-28 Gilead Sciences, Inc. Integrase inhibitors
US8993542B2 (en) 2008-01-25 2015-03-31 Chimerix Inc. Methods of treating viral infections
US8815906B2 (en) 2008-03-19 2014-08-26 Chembridge Corporation Tyrosine kinase inhibitors
US9249147B2 (en) 2008-03-19 2016-02-02 Chembridge Corporation Tyrosine kinase inhibitors
MX2011010582A (es) * 2009-04-09 2011-10-19 Boehringer Ingelheim Int Inhibidores de la replicacion del vih.
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
AU2011216243B2 (en) 2010-02-12 2015-07-09 Chimerix, Inc. Nucleoside phosphonate salts
WO2012037155A2 (en) 2010-09-13 2012-03-22 Gtx, Inc. Tyrosine kinase inhibitors
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
CA3106239A1 (en) 2018-07-27 2020-01-30 Biotheryx, Inc. Bifunctional compounds as cdk modulators
EP4143329A2 (en) 2020-04-28 2023-03-08 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544732B1 (en) * 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
DE60124577T2 (de) * 2000-10-12 2007-09-27 Merck & Co., Inc. Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
AU2003301439A1 (en) * 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
US7442773B2 (en) * 2004-01-23 2008-10-28 The Board Of Trustees Of The University Of Illinois Universal peptide-binding scaffolds and protein chips

Also Published As

Publication number Publication date
US20060211724A1 (en) 2006-09-21
MXPA05011726A (es) 2006-01-23
CN1812992A (zh) 2006-08-02
KR20060006047A (ko) 2006-01-18
AR044518A1 (es) 2005-09-14
CA2522990A1 (en) 2004-11-11
BRPI0409873A (pt) 2006-05-16
AU2004234087A1 (en) 2004-11-11
TW200507848A (en) 2005-03-01
EP1625130A2 (en) 2006-02-15
WO2004096807A2 (en) 2004-11-11
WO2004096807A3 (en) 2005-01-06
WO2004096807A8 (en) 2005-09-22
AP2005003451A0 (en) 2005-12-31

Similar Documents

Publication Publication Date Title
NO20055230L (no) HIV-integraseinhibitorer
CO2022010098A2 (es) Inhibidores de proteínas kras mutantes
MA54327B1 (fr) Inhibiteurs de kras g12c
PE20240765A1 (es) Compuestos para la inhibicion de nlrp3 y usos de estos
MA45920B1 (fr) Inhibiteurs de pyridopyrimidinone cdk2/4/6
MA42292B1 (fr) Dérivés de sulfamoylarylamide cyclisés et leur utilisation à titre de médicaments pour le traitement de l'hépatite b
PE20230376A1 (es) Compuestos moduladores de la diacilglicerol quinasa
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
PE20060692A1 (es) Inhibidores bace
MA31763B1 (fr) Inhibiteurs de kinase de type polo
AR065093A1 (es) Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
CR9690A (es) 3-acilaminobenzanilidas insecticidas
PE20081448A1 (es) Inhibidores de transcriptasa inversa no nucleosidicos
MA31419B1 (fr) Derives de pyridine
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
AR054214A1 (es) Compuestos derivados de 1, 1 - dioxotiadiazina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la infeccion por el virus de la hepatitis c.
AR057072A1 (es) Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
AR051795A1 (es) Derivados de hidantoina inhibidores de metaloproteinasas
PE20190106A1 (es) Inhibidores del potenciador del homologo zeste 2
AR051797A1 (es) Derivados de hidantoina inhibidores de metaloproteinasas
EA200970052A1 (ru) 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы
PE20220252A1 (es) Compuestos de pirrol
CO2021014255A2 (es) Composiciones antifúngicas
AR049668A1 (es) Proceso quimico para preparar esteres de 4,4 - difluorometil - 3 - oxo - butanoico por reaccion entre una amida y un ester.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application